Trial of polyunsaturated fatty acids in non-relapsing multiple sclerosis.
作者信息
Bates D, Fawcett P R, Shaw D A, Weightman D
出版信息
Br Med J. 1977 Oct 8;2(6092):932-3. doi: 10.1136/bmj.2.6092.932-a.
Abstract
摘要
相似文献
1
Trial of polyunsaturated fatty acids in non-relapsing multiple sclerosis.非复发性多发性硬化症中多不饱和脂肪酸的试验。
Br Med J. 1977 Oct 8;2(6092):932-3. doi: 10.1136/bmj.2.6092.932-a.
2
Polyunsaturated fatty acids in the pathogenesis and treatment of multiple sclerosis.多不饱和脂肪酸在多发性硬化症的发病机制及治疗中的作用
Br J Nutr. 2007 Oct;98 Suppl 1:S46-53. doi: 10.1017/S0007114507833010.
3
Polyunsaturated fatty acids in multiple sclerosis.多发性硬化症中的多不饱和脂肪酸
Br Med J. 1979 Mar 10;1(6164):683. doi: 10.1136/bmj.1.6164.683.
4
Polyunsaturated fatty acids and colchicine in multiple sclerosis.多发性硬化症中的多不饱和脂肪酸与秋水仙碱
Br Med J. 1979 Feb 10;1(6160):411-2. doi: 10.1136/bmj.1.6160.411-a.
5
Polyunsaturated fatty acids and colchicine in multiple sclerosis.多发性硬化症中的多不饱和脂肪酸与秋水仙碱
Br Med J. 1979 Jan 20;1(6157):199-200. doi: 10.1136/bmj.1.6157.199-d.
6
Polyunsaturated fatty acids and their potential therapeutic role in multiple sclerosis.多不饱和脂肪酸及其在多发性硬化症中的潜在治疗作用。
Nat Clin Pract Neurol. 2009 Feb;5(2):82-92. doi: 10.1038/ncpneuro1009.
7
MaxEPA in multiple sclerosis.
Br J Clin Pract Suppl. 1984;31:117-21.
8
Multiple sclerosis and MaxEPA.多发性硬化症与MaxEPA（一种富含ω-3脂肪酸的营养补充剂，通常指浓缩鱼油）
Br J Clin Pract. 1986 Sep;40(9):365-7.
9
Polyunsaturated fatty acids in multiple sclerosis.多发性硬化症中的多不饱和脂肪酸
Br Med J. 1977 Nov 5;2(6096):1217. doi: 10.1136/bmj.2.6096.1217.
10
Supplementation of polyunsaturated fatty acids in multiple sclerosis.
Ital J Neurol Sci. 1992 Jun;13(5):401-7. doi: 10.1007/BF02312146.
引用本文的文献
1
Omega-6 fatty acids and the risk of cardiovascular disease: insights from a systematic review and meta-analysis of randomized controlled trials and a Mendelian randomization study.ω-6脂肪酸与心血管疾病风险：来自随机对照试验的系统评价和荟萃分析以及孟德尔随机化研究的见解
Arch Med Sci. 2021 Apr 24;18(2):466-479. doi: 10.5114/aoms/136070. eCollection 2022.
2
Dietary interventions for multiple sclerosis-related outcomes.针对多发性硬化症相关结局的饮食干预措施。
Cochrane Database Syst Rev. 2020 May 19;5(5):CD004192. doi: 10.1002/14651858.CD004192.pub4.
3
[Aspects of nutrition for prevention and treatment of chronic neurological diseases].[慢性神经疾病防治的营养方面]
Nervenarzt. 2019 Aug;90(8):843-857. doi: 10.1007/s00115-019-0756-9.
4
Omega-6 fats for the primary and secondary prevention of cardiovascular disease.用于心血管疾病一级和二级预防的欧米伽-6脂肪酸。
Cochrane Database Syst Rev. 2018 Nov 29;11(11):CD011094. doi: 10.1002/14651858.CD011094.pub4.
5
Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease.多不饱和脂肪酸用于心血管疾病的一级和二级预防
Cochrane Database Syst Rev. 2018 Nov 27;11(11):CD012345. doi: 10.1002/14651858.CD012345.pub3.
6
The Role of Diet in Multiple Sclerosis: Mechanistic Connections and Current Evidence.饮食在多发性硬化中的作用：机制关联和现有证据。
Curr Nutr Rep. 2018 Sep;7(3):150-160. doi: 10.1007/s13668-018-0236-z.
7
Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease.用于心血管疾病一级和二级预防的多不饱和脂肪酸
Cochrane Database Syst Rev. 2018 Jul 18;7(7):CD012345. doi: 10.1002/14651858.CD012345.pub2.
8
Omega-6 fats for the primary and secondary prevention of cardiovascular disease.用于心血管疾病一级和二级预防的欧米伽-6脂肪酸。
Cochrane Database Syst Rev. 2018 Jul 18;7(7):CD011094. doi: 10.1002/14651858.CD011094.pub3.
9
Modulation of Multiple Sclerosis and Its Animal Model Experimental Autoimmune Encephalomyelitis by Food and Gut Microbiota.食物与肠道微生物群对多发性硬化症及其动物模型实验性自身免疫性脑脊髓炎的调节作用
Front Immunol. 2017 Sep 5;8:1081. doi: 10.3389/fimmu.2017.01081. eCollection 2017.
10
Dietary Interventions in Multiple Sclerosis: Development and Pilot-Testing of an Evidence Based Patient Education Program.多发性硬化症的饮食干预：一项基于证据的患者教育计划的制定与初步测试
PLoS One. 2016 Oct 20;11(10):e0165246. doi: 10.1371/journal.pone.0165246. eCollection 2016.
本文引用的文献
1
On the evaluation of disability in multiple sclerosis.关于多发性硬化症残疾情况的评估。
Neurology. 1961 Aug;11:686-94. doi: 10.1212/wnl.11.8.686.
Zotero 插件